Formulation Development Outsourcing Market By Services Type (Pre-Formulation, Formulation Development), By Route of Formulation (Oral, Injectable, Others), By End-user (Pharmaceutical Industries, Research and Academic Institutes): Global Opportunity Analysis and Industry Forecast, 2021-2031

Formulation Development Outsourcing Market

Formulation development is a crucial aspect of product/drug development that affects a pharmaceutical product's patentability, lifetime, and success. To cut down on the amount of time and money spent on trials, the majority of pharmaceutical corporations outsource formulation services. Global regulatory authorities have established stringent requirements to assure data quality and integrity, which are defined by the FDA. Due in large part to the increasing number of key medications whose patents are expiring, as well as the rising outsourcing of formulation development services by the majority of pharmaceutical and biotechnological businesses, the industry is expected to grow. To reduce risk and save time and money while moving a medicine through the development phase, a majority of pharma companies collaborate with outsourcing services in the early stages of drug development.

The large number of formulation development outsourcing companies are partnering with Contract Development and Manufacturing Organization's to minimize the timeline needed for manufacturing of drugs or vaccines and to mitigate the risk. The formulation development outsourcing manufacturing and packaging offers complete analytical and technical support with enhanced launch capabilities and final distribution. The formulation development outsourcing facilitates development activities within compressed timeline with timely resolution of development challenges to facilitate the alignment of various components in the supply chain. Formulation development outsourcing facilitates early development activities to fasten the development activities and to accelerate the clinical trial entry. Additionally, several small pharmaceutical companies are outsourcing the formulation development outsourcing activities for the early phase development and clinical trials. The formulation development outsourcing companies are accelerating the development of technologies for both GMP and non-GMP products to facilitate the increasing scale demand of pharmaceutical products during the product development lifecycle. Thus, the formulation development outsourcing companies are implementing 'reserved capacity model' to provide access to formulation, manufacturing, and outsourcing activities that can boost the clinical and commercial supply chain. These factors are anticipated to generate excellent opportunities in the formulation development outsourcing market in the coming years.

Diabetes, chronic obstructive pulmonary disease (COPD), cancer, asthma, arthritis, and Alzheimer's disease are all on the rise, fueling the demand for new medication discovery and development. This, in turn, is one of the primary reasons why formulation development services are being outsourced to contract research organizations (CROs) all over the world. As a result, top pharmaceutical and biotechnology businesses throughout the world are collaborating with outsourcing services in the early stages of drug development. This, along with a significant increase in the need to innovate novel drugs on account of the rising patent expirations of major drugs, is contributing to market growth. All these factors are projected to create numerous growth prospects for the key players operating in the market.

The formulation development outsourcing market is segmented into services type, route of formulation, end user, and region. On the basis of service type, the market is categorized into pre-formulation and formulation development. On the basis of route of formulation, it is categorized into oral, injectable and other. On the basis of end user, it is bifurcated into pharmaceutical industries and research and academic institutes. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (the UK, Germany, Italy, France, Spain, and rest of Europe), Asia-Pacific (China, India, Japan, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, United Arab Emirates, South Africa, and rest of LAMEA).

The key players profiled in the study include Charles River Laboratories., Syngene International Limited, Catalent, Inc, Piramal Pharma Ltd., Intertek Group plc., Thermo Fisher Scientific, Eurofins Scientific, Laboratory Corporation of America Holdings., Dr. Reddy’s Laboratories Ltd., and EMERGENT.

The players in the market have been actively engaged in the adoption various strategies such as acquisition, product launch and expansion to remain competitive and gain advantage over the competitors in the market. For instance,  in June 2022  Lonza opened a new R&D centre in Bend to assist early-phase clinical studies.

Key Market Insights

 By services type, the formulation development segment was the highest revenue contributor to the market in 2021. However, the pre-formulation segment is estimated to be the fastest growing during the forecast period

By route of formulation, the injectable segment dominated the global market in 2021 and oral segment is estimated to be the fastest growing during the forecast years

 Based on end-user, the pharmaceutical industries segment was the highest revenue contributor to the market in 2021 and is projected to be the fastest growing during the forecast period.  

Based on region, Asia-Pacific was the highest revenue contributor to the market in 2031, accounting for a market size of $17490.7 million

 

Overview

The global formulation development outsourcing market is envisioned to garner $6518.8 million by 2031, growing from $3156.8 million in 2021 at a CAGR of 9.0% from 2022 to 2031. The process of assessing the patentability, lifetime, and success of pharmaceutical products is referred to as formulation development. Pre-formulation activities include the development and characterization of analytical assays, excipient screening to stabilize or improve the product's solubility, and dosage form. Due to time constraints and a lack of internal resources, it is frequently outsourced. Outsourcing formulation development has a lot of advantages as well, including shortened timescales, easier access to knowledge, and increased protection against defective products.

Drug developers at all levels are becoming interested in outsourcing pharmaceutical formulation development and manufacture, particularly in developing nations like India. The rising need for novel medications as a result of the significant burden of infectious and chronic diseases is one of the main factors driving the demand for formulation development. In addition, there is a strong emphasis on creating poorly water-soluble chemicals to increase bioavailability and patent expirations. The necessity for clinical trials to identify a cure for contagious viruses has also been influenced by the COVID-19 outbreak. As a result, substantial funds have been spent on R&D to create medicines, which are predicted to boost the industry.

It is anticipated that higher R&D expenses will raise demand for outsourcing formulation development. Small and medium-sized pharmaceutical enterprises that lack the requisite resources frequently use outsourcing services for formulation development. Due to trial-related expenses, the majority of pharmaceutical businesses use it to shorten the time spent on outsourcing services for formulation development. The pharmaceutical industry's growing reliance on collaborations with academic institutions is caused by the growth of the formulation development outsourcing industry.

The formulation development outsourcing market is expected to be restrained owing to high amount of budget required for outsourcing drug development by the companies. Additionally, the complexity of the substances is growing for formulators. Increases in the price and demand for various medicines and raw materials have the potential to have a substantial negative impact on the market value of formulation development outsourcing. Incorporating various active chemicals, tightening restrictions, shifting societal and customer preferences, and environmental considerations all have an impact on the creation of a product, as do usage and eventual decomposition. In addition to their total environmental impact, formulators are concerned with how their products will benefit consumers and patients.

The number of pharmaceutical and biopharmaceutical businesses outsourcing their work has led to an expansion of the formulation development outsourcing market. The COVID-19 pandemic is expected to have a positive impact on the formulation drug outsourcing market. The high demand for effective drug or vaccine discovery among healthcare professionals, researchers and scientists to treat the viral infection has boosted the research and development activities. Many contract formulation development outsourcing companies became active and started taking drug development formulation projects from major companies and even research institutes.

The key players profiled in this report include Charles River Laboratories, Syngene International Limited, Catalent, Inc, Piramal Pharma Ltd., Intertek Group plc, Thermo Fisher Scientific, Eurofins Scientific, Laboratory Corporation of America Holdings., Dr. Reddy’s Laboratories Ltd., and EMERGENT.

Key Benefits For Stakeholders

●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the formulation development outsourcing market analysis from 2021 to 2031 to identify the prevailing formulation development outsourcing market opportunities.

●The market research is offered along with information related to key drivers, restraints, and opportunities.

●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

●In-depth analysis of the formulation development outsourcing market segmentation assists to determine the prevailing market opportunities.

●Major countries in each region are mapped according to their revenue contribution to the global market.

●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

●The report includes the analysis of the regional as well as global formulation development outsourcing market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

○ Emergent BioSolutions, Inc

Scope of Formulation Development Outsourcing Market Report

1.1. Report description

1.2. Key market segments

1.3. Key benefits to the stakeholders

1.4. Research Methodology

1.4.1. Primary research

1.4.2. Secondary research

1.4.3. Analyst tools and models

2.1. CXO Perspective

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top impacting factors

3.2.2. Top investment pockets

3.3. Porter’s five forces analysis

3.4. Market dynamics

3.4.1. Drivers

3.4.2. Restraints

3.4.3. Opportunities

3.5. COVID-19 Impact Analysis on the market

3.6. Key Regulation Analysis

3.7. Market Share Analysis

3.8. Patent Landscape

3.9. Regulatory Guidelines

3.10. Value Chain Analysis

4.1. Overview

4.1.1. Market size and forecast

4.2. Pre-Formulation

4.2.1. Key market trends, growth factors and opportunities

4.2.2. Market size and forecast, by region

4.2.3. Market share analysis by country

4.3. Formulation Development

4.3.1. Key market trends, growth factors and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market share analysis by country

5.1. Overview

5.1.1. Market size and forecast

5.2. Oral

5.2.1. Key market trends, growth factors and opportunities

5.2.2. Market size and forecast, by region

5.2.3. Market share analysis by country

5.3. Injectable

5.3.1. Key market trends, growth factors and opportunities

5.3.2. Market size and forecast, by region

5.3.3. Market share analysis by country

5.4. Others

5.4.1. Key market trends, growth factors and opportunities

5.4.2. Market size and forecast, by region

5.4.3. Market share analysis by country

6.1. Overview

6.1.1. Market size and forecast

6.2. Pharmaceutical Industries

6.2.1. Key market trends, growth factors and opportunities

6.2.2. Market size and forecast, by region

6.2.3. Market share analysis by country

6.3. Research and Academic Institutes

6.3.1. Key market trends, growth factors and opportunities

6.3.2. Market size and forecast, by region

6.3.3. Market share analysis by country

7.1. Overview

7.1.1. Market size and forecast By Region

7.2. North America

7.2.1. Key trends and opportunities

7.2.2. Market size and forecast, by Services Type

7.2.3. Market size and forecast, by Route of Formulation

7.2.4. Market size and forecast, by End-user

7.2.5. Market size and forecast, by country

7.2.5.1. U.S.

7.2.5.1.1. Key market trends, growth factors and opportunities

7.2.5.1.2. Market size and forecast, by Services Type

7.2.5.1.3. Market size and forecast, by Route of Formulation

7.2.5.1.4. Market size and forecast, by End-user

7.2.5.2. Canada

7.2.5.2.1. Key market trends, growth factors and opportunities

7.2.5.2.2. Market size and forecast, by Services Type

7.2.5.2.3. Market size and forecast, by Route of Formulation

7.2.5.2.4. Market size and forecast, by End-user

7.2.5.3. Mexico

7.2.5.3.1. Key market trends, growth factors and opportunities

7.2.5.3.2. Market size and forecast, by Services Type

7.2.5.3.3. Market size and forecast, by Route of Formulation

7.2.5.3.4. Market size and forecast, by End-user

7.3. Europe

7.3.1. Key trends and opportunities

7.3.2. Market size and forecast, by Services Type

7.3.3. Market size and forecast, by Route of Formulation

7.3.4. Market size and forecast, by End-user

7.3.5. Market size and forecast, by country

7.3.5.1. Germany

7.3.5.1.1. Key market trends, growth factors and opportunities

7.3.5.1.2. Market size and forecast, by Services Type

7.3.5.1.3. Market size and forecast, by Route of Formulation

7.3.5.1.4. Market size and forecast, by End-user

7.3.5.2. UK

7.3.5.2.1. Key market trends, growth factors and opportunities

7.3.5.2.2. Market size and forecast, by Services Type

7.3.5.2.3. Market size and forecast, by Route of Formulation

7.3.5.2.4. Market size and forecast, by End-user

7.3.5.3. France

7.3.5.3.1. Key market trends, growth factors and opportunities

7.3.5.3.2. Market size and forecast, by Services Type

7.3.5.3.3. Market size and forecast, by Route of Formulation

7.3.5.3.4. Market size and forecast, by End-user

7.3.5.4. Spain

7.3.5.4.1. Key market trends, growth factors and opportunities

7.3.5.4.2. Market size and forecast, by Services Type

7.3.5.4.3. Market size and forecast, by Route of Formulation

7.3.5.4.4. Market size and forecast, by End-user

7.3.5.5. Italy

7.3.5.5.1. Key market trends, growth factors and opportunities

7.3.5.5.2. Market size and forecast, by Services Type

7.3.5.5.3. Market size and forecast, by Route of Formulation

7.3.5.5.4. Market size and forecast, by End-user

7.3.5.6. Rest of Europe

7.3.5.6.1. Key market trends, growth factors and opportunities

7.3.5.6.2. Market size and forecast, by Services Type

7.3.5.6.3. Market size and forecast, by Route of Formulation

7.3.5.6.4. Market size and forecast, by End-user

7.4. Asia-Pacific

7.4.1. Key trends and opportunities

7.4.2. Market size and forecast, by Services Type

7.4.3. Market size and forecast, by Route of Formulation

7.4.4. Market size and forecast, by End-user

7.4.5. Market size and forecast, by country

7.4.5.1. China

7.4.5.1.1. Key market trends, growth factors and opportunities

7.4.5.1.2. Market size and forecast, by Services Type

7.4.5.1.3. Market size and forecast, by Route of Formulation

7.4.5.1.4. Market size and forecast, by End-user

7.4.5.2. Japan

7.4.5.2.1. Key market trends, growth factors and opportunities

7.4.5.2.2. Market size and forecast, by Services Type

7.4.5.2.3. Market size and forecast, by Route of Formulation

7.4.5.2.4. Market size and forecast, by End-user

7.4.5.3. India

7.4.5.3.1. Key market trends, growth factors and opportunities

7.4.5.3.2. Market size and forecast, by Services Type

7.4.5.3.3. Market size and forecast, by Route of Formulation

7.4.5.3.4. Market size and forecast, by End-user

7.4.5.4. South Korea

7.4.5.4.1. Key market trends, growth factors and opportunities

7.4.5.4.2. Market size and forecast, by Services Type

7.4.5.4.3. Market size and forecast, by Route of Formulation

7.4.5.4.4. Market size and forecast, by End-user

7.4.5.5. Australia

7.4.5.5.1. Key market trends, growth factors and opportunities

7.4.5.5.2. Market size and forecast, by Services Type

7.4.5.5.3. Market size and forecast, by Route of Formulation

7.4.5.5.4. Market size and forecast, by End-user

7.4.5.6. Rest of Asia-Pacific

7.4.5.6.1. Key market trends, growth factors and opportunities

7.4.5.6.2. Market size and forecast, by Services Type

7.4.5.6.3. Market size and forecast, by Route of Formulation

7.4.5.6.4. Market size and forecast, by End-user

7.5. LAMEA

7.5.1. Key trends and opportunities

7.5.2. Market size and forecast, by Services Type

7.5.3. Market size and forecast, by Route of Formulation

7.5.4. Market size and forecast, by End-user

7.5.5. Market size and forecast, by country

7.5.5.1. Brazil

7.5.5.1.1. Key market trends, growth factors and opportunities

7.5.5.1.2. Market size and forecast, by Services Type

7.5.5.1.3. Market size and forecast, by Route of Formulation

7.5.5.1.4. Market size and forecast, by End-user

7.5.5.2. Saudi Arabia

7.5.5.2.1. Key market trends, growth factors and opportunities

7.5.5.2.2. Market size and forecast, by Services Type

7.5.5.2.3. Market size and forecast, by Route of Formulation

7.5.5.2.4. Market size and forecast, by End-user

7.5.5.3. United Arab Emirates

7.5.5.3.1. Key market trends, growth factors and opportunities

7.5.5.3.2. Market size and forecast, by Services Type

7.5.5.3.3. Market size and forecast, by Route of Formulation

7.5.5.3.4. Market size and forecast, by End-user

7.5.5.4. South Africa

7.5.5.4.1. Key market trends, growth factors and opportunities

7.5.5.4.2. Market size and forecast, by Services Type

7.5.5.4.3. Market size and forecast, by Route of Formulation

7.5.5.4.4. Market size and forecast, by End-user

7.5.5.5. Rest of LAMEA

7.5.5.5.1. Key market trends, growth factors and opportunities

7.5.5.5.2. Market size and forecast, by Services Type

7.5.5.5.3. Market size and forecast, by Route of Formulation

7.5.5.5.4. Market size and forecast, by End-user

8.1. Introduction

8.2. Top winning strategies

8.3. Product Mapping of Top 10 Player

8.4. Competitive Dashboard

8.5. Competitive Heatmap

8.6. Top player positioning, 2021

9.1. Charles River Laboratories International, Inc.

9.1.1. Company overview

9.1.2. Key Executives

9.1.3. Company snapshot

9.2. syngene international limited

9.2.1. Company overview

9.2.2. Key Executives

9.2.3. Company snapshot

9.3. Catalent Inc

9.3.1. Company overview

9.3.2. Key Executives

9.3.3. Company snapshot

9.4. Piramal Pharma Limited

9.4.1. Company overview

9.4.2. Key Executives

9.4.3. Company snapshot

9.5.  Intertek Group Plc

9.5.1. Company overview

9.5.2. Key Executives

9.5.3. Company snapshot

9.6. Thermo Fisher Scientific Inc.

9.6.1. Company overview

9.6.2. Key Executives

9.6.3. Company snapshot

9.7. Eurofins Scientific

9.7.1. Company overview

9.7.2. Key Executives

9.7.3. Company snapshot

9.8. Laboratory Corporation of America Holdings

9.8.1. Company overview

9.8.2. Key Executives

9.8.3. Company snapshot

9.9. Dr Reddy's Laboratories Ltd.

9.9.1. Company overview

9.9.2. Key Executives

9.9.3. Company snapshot

9.10. Emergent BioSolutions, Inc.

9.10.1. Company overview

9.10.2. Key Executives

9.10.3. Company snapsho

LIST OF TABLES

TABLE 01. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 02. FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR PRE-FORMULATION, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 03. FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR FORMULATION DEVELOPMENT, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 04. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)

TABLE 05. FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR ORAL, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 06. FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR INJECTABLE, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 07. FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 08. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)

TABLE 09. FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR PHARMACEUTICAL INDUSTRIES, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 10. FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 11. FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 12. NORTH AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 13. NORTH AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)

TABLE 14. NORTH AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)

TABLE 15. NORTH AMERICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 16. U.S. FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 17. U.S. FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)

TABLE 18. U.S. FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)

TABLE 19. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 20. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)

TABLE 21. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)

TABLE 22. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 23. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)

TABLE 24. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)

TABLE 25. EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 26. EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)

TABLE 27. EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)

TABLE 28. EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 29. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 30. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)

TABLE 31. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)

TABLE 32. UK FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 33. UK FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)

TABLE 34. UK FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)

TABLE 35. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 36. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)

TABLE 37. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)

TABLE 38. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 39. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)

TABLE 40. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)

TABLE 41. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 42. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)

TABLE 43. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)

TABLE 44. REST OF EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 45. REST OF EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)

TABLE 46. REST OF EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)

TABLE 47. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 48. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)

TABLE 49. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)

TABLE 50. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 51. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 52. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)

TABLE 53. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)

TABLE 54. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 55. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)

TABLE 56. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)

TABLE 57. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 58. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)

TABLE 59. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)

TABLE 60. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 61. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)

TABLE 62. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)

TABLE 63. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 64. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)

TABLE 65. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)

TABLE 66. REST OF ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 67. REST OF ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)

TABLE 68. REST OF ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)

TABLE 69. LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 70. LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)

TABLE 71. LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)

TABLE 72. LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 73. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 74. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)

TABLE 75. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)

TABLE 76. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 77. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)

TABLE 78. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)

TABLE 79. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 80. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)

TABLE 81. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)

TABLE 82. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 83. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)

TABLE 84. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)

TABLE 85. REST OF LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 86. REST OF LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021-2031 (REVENUE, $MILLION)

TABLE 87. REST OF LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021-2031 (REVENUE, $MILLION)

TABLE 88. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: KEY EXECUTIVES

TABLE 89. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT

TABLE 90. SYNGENE INTERNATIONAL LIMITED: KEY EXECUTIVES

TABLE 91. SYNGENE INTERNATIONAL LIMITED: COMPANY SNAPSHOT

TABLE 92. CATALENT INC: KEY EXECUTIVES

TABLE 93. CATALENT INC: COMPANY SNAPSHOT

TABLE 94. PIRAMAL PHARMA LIMITED: KEY EXECUTIVES

TABLE 95. PIRAMAL PHARMA LIMITED: COMPANY SNAPSHOT

TABLE 96.  INTERTEK GROUP PLC: KEY EXECUTIVES

TABLE 97.  INTERTEK GROUP PLC: COMPANY SNAPSHOT

TABLE 98. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES

TABLE 99. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT

TABLE 100. EUROFINS SCIENTIFIC: KEY EXECUTIVES

TABLE 101. EUROFINS SCIENTIFIC: COMPANY SNAPSHOT

TABLE 102. LABORATORY CORPORATION OF AMERICA HOLDINGS: KEY EXECUTIVES

TABLE 103. LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT

TABLE 104. DR REDDY'S LABORATORIES LTD.: KEY EXECUTIVES

TABLE 105. DR REDDY'S LABORATORIES LTD.: COMPANY SNAPSHOT

TABLE 106. EMERGENT BIOSOLUTIONS, INC.: KEY EXECUTIVES

TABLE 107. EMERGENT BIOSOLUTIONS, INC.: COMPANY SNAPSHOT LIST OF FIGURES

FIGURE 01. FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031

FIGURE 02. SEGMENTATION OF FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031

FIGURE 03. TOP INVESTMENT POCKETS IN FORMULATION DEVELOPMENT OUTSOURCING MARKET (2022-2031)

FIGURE 04. PORTER FIVE-1

FIGURE 05. PORTER FIVE-2

FIGURE 06. PORTER FIVE-3

FIGURE 07. PORTER FIVE-4

FIGURE 08. PORTER FIVE-5

FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALFORMULATION DEVELOPMENT OUTSOURCING MARKET

FIGURE 10. IMPACT OF KEY REGULATION: FORMULATION DEVELOPMENT OUTSOURCING MARKET

FIGURE 11. MARKET SHARE ANALYSIS: FORMULATION DEVELOPMENT OUTSOURCING MARKET

FIGURE 12. PATENT ANALYSIS BY COMPANY

FIGURE 13. PATENT ANALYSIS BY COUNTRY

FIGURE 14. REGULATORY GUIDELINES: FORMULATION DEVELOPMENT OUTSOURCING MARKET

FIGURE 15. VALUE CHAIN ANALYSIS: FORMULATION DEVELOPMENT OUTSOURCING MARKET

FIGURE 16. FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY SERVICES TYPE, 2021(%)

FIGURE 17. COMPARATIVE SHARE ANALYSIS OF FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR PRE-FORMULATION, BY COUNTRY 2021-2031(%)

FIGURE 18. COMPARATIVE SHARE ANALYSIS OF FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR FORMULATION DEVELOPMENT, BY COUNTRY 2021-2031(%)

FIGURE 19. FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY ROUTE OF FORMULATION, 2021(%)

FIGURE 20. COMPARATIVE SHARE ANALYSIS OF FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR ORAL, BY COUNTRY 2021-2031(%)

FIGURE 21. COMPARATIVE SHARE ANALYSIS OF FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR INJECTABLE, BY COUNTRY 2021-2031(%)

FIGURE 22. COMPARATIVE SHARE ANALYSIS OF FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)

FIGURE 23. FORMULATION DEVELOPMENT OUTSOURCING MARKET, BY END-USER, 2021(%)

FIGURE 24. COMPARATIVE SHARE ANALYSIS OF FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR PHARMACEUTICAL INDUSTRIES, BY COUNTRY 2021-2031(%)

FIGURE 25. COMPARATIVE SHARE ANALYSIS OF FORMULATION DEVELOPMENT OUTSOURCING MARKET FOR RESEARCH AND ACADEMIC INSTITUTES, BY COUNTRY 2021-2031(%)

FIGURE 26. FORMULATION DEVELOPMENT OUTSOURCING MARKET BY REGION, 2021

FIGURE 27. U.S. FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)

FIGURE 28. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)

FIGURE 29. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)

FIGURE 30. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)

FIGURE 31. UK FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)

FIGURE 32. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)

FIGURE 33. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)

FIGURE 34. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)

FIGURE 35. REST OF EUROPE FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)

FIGURE 36. CHINA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)

FIGURE 37. JAPAN FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)

FIGURE 38. INDIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)

FIGURE 39. SOUTH KOREA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)

FIGURE 40. AUSTRALIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)

FIGURE 41. REST OF ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)

FIGURE 42. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)

FIGURE 43. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)

FIGURE 44. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)

FIGURE 45. SOUTH AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)

FIGURE 46. REST OF LAMEA FORMULATION DEVELOPMENT OUTSOURCING MARKET, 2021-2031 ($MILLION)

FIGURE 47. TOP WINNING STRATEGIES, BY YEAR

FIGURE 48. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 49. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 50. PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 51. COMPETITIVE DASHBOARD

FIGURE 52. COMPETITIVE HEATMAP: FORMULATION DEVELOPMENT OUTSOURCING MARKET

FIGURE 53. TOP PLAYER POSITIONING, 202